Skip Navigation

Cardiovascular Research 1993 27(9):1691-1697; doi:10.1093/cvr/27.9.1691
© 1993 by European Society of Cardiology
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fu, Y.-M.
Right arrow Articles by Epstein, S. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fu, Y.-M.
Right arrow Articles by Epstein, S. E
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1993, European Society of Cardiology

Cytotoxic effects of vascular smooth muscle cells of the chimeric toxin, heparin binding TGF{alpha}-Pseudomonas exotoxin

Ya-Min Fu, Enrique A Mesri, Zu-Xi Yu, Robert J Kreitman, Ira Pastan and Stephen E Epstein

National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA – Cardiology Branch: Y-M Fu, Z-X Yu, S E Epstein; Laboratory of Molecular Biology, Division of Cancer Diagnosis: E A Mesri, R J Kreitman, I Pastan.

Correspondence to Dr Epstein (Building 10, Room 7B15).

Objective: Smooth muscle cell proliferation appears to be very important in restenosis after angioplasty. A chimeric toxin created by genetically fusing the gene encoding TGF{alpha} (targets the EGF receptor) to the gene encoding Pseudomonas exotoxin (PE) preferentially kills rapidly proliferating smooth muscle cells. Recently, a heparin binding EGF-like growth factor (HB-EGF) has been identified. The HB domain enhances the mitogenic activity for smooth muscle cells. The purpose of this study was to design a new chimeric toxin, having both heparin binding and EGF receptor binding function, and to determine whether it is more cytotoxic to smooth muscle cells. Methods: By recombinant DNA techniques, a new chimeric toxin, HB-TGF{alpha}-PE4EKDEL, was synthesised. Cytotoxic assays were performed by assessing the capacity to inhibit protein synthesis of rat vascular smooth muscle cells. Results: The toxin preferentially killed rapidly proliferating smooth muscle cells (p < 0.025). The HB domain increased the cytotoxicity of the molecule when compared to the other chimeric toxins tested against smooth muscle cells. The cytotoxic effect of the new molecule was significantly decreased by exogenously added heparin (p < 0.05). Conclusions: The presence of a heparin binding domain increases the smooth muscle cell cytotoxicity of the TGFa fusion toxin, perhaps because HB-TGFa-PE4EKDEL functions as a molecule with two ligands. It will be important to determine whether the greater smooth muscle cell cytotoxicity that exists in vitro will facilitate the specific targeting and killing of rapidly proliferating cells in vivo.

Cardiovascular Research 1993;27:1691-1697

KEYWORDS EGF; proliferation; restenosis

The authors gratefully acknowledge the expert help of Dr Victor Ferrans in interpreting the electron microscopic studies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
Y.-M. Fu, Z.-X. Yu, B. A. Pelayo, V. J. Ferrans, and G. G. Meadows
Focal Adhesion Kinase-dependent Apoptosis of Melanoma Induced by Tyrosine and Phenylalanine Deficiency
Cancer Res., February 1, 1999; 59(3): 758 - 765.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
E. Mesri, M Ono, R. Kreitman, M Klagsbrun, and I Pastan
The heparin-binding domain of heparin-binding EGF-like growth factor can target Pseudomonas exotoxin to kill cells exclusively through heparan sulfate proteoglycans
J. Cell Sci., January 9, 1994; 107(9): 2599 - 2608.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.